Yao K, Karasawa A
Department of Pharmacology, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.
Biol Pharm Bull. 1994 Apr;17(4):517-21. doi: 10.1248/bpb.17.517.
We investigated the possible protective effects of benidipine (Coniel), a calcium antagonist, on mechanical dysfunction, metabolic damage and changes in vascular reactivity during ischemia and reperfusion in the Langendorff-perfused rat heart. The responses of perfusion pressure to U-46619, a vasoconstrictor, and acetylcholine, an endothelial-dependent vasodilator, were also determined as indices of the vascular function. Thirty min of reperfusion following 30 min of global ischemia produced contractile failure and the marked release of lactate dehydrogenase (LDH) and creatine phosphokinase (CPK). Additionally, the ischemia and reperfusion augmented the vasoconstrictor response to U-46619, and depressed the endothelium-dependent vasodilator response to acetylcholine. These hearts were treated with 1 or 10 nM benidipine from 20 min before ischemia to the beginning of ischemia. While benidipine at 10 nM had a modest negative inotropic action, 1 nM of this drug had minimal depressant effects on the preischemic function. The depressed contractile function after the ischemia was improved, and the increased releases of LDH and CPK were significantly ameliorated by benidipine. Also, benidipine restored the augmented contractile response to U-46619 and preserved the vasodilator response to acetylcholine. These results demonstrate that pretreatment with benidipine prevents myocardial injury following ischemia and reperfusion. The cardioprotective effects of benidipine may in part be due to the protection of vascular reactivity by this drug.
我们研究了钙拮抗剂贝尼地平(Coniel)对Langendorff灌注大鼠心脏缺血再灌注期间机械功能障碍、代谢损伤及血管反应性变化的可能保护作用。还测定了灌注压力对血管收缩剂U - 46619和内皮依赖性血管舒张剂乙酰胆碱的反应,以此作为血管功能指标。全心缺血30分钟后再灌注30分钟导致收缩功能衰竭,并显著释放乳酸脱氢酶(LDH)和肌酸磷酸激酶(CPK)。此外,缺血再灌注增强了对U - 46619的血管收缩反应,并降低了对乙酰胆碱的内皮依赖性血管舒张反应。从缺血前20分钟至缺血开始,用1或10 nM贝尼地平处理这些心脏。虽然10 nM的贝尼地平有适度的负性肌力作用,但1 nM的该药物对缺血前功能的抑制作用最小。贝尼地平改善了缺血后的收缩功能障碍,并显著减轻了LDH和CPK释放的增加。此外,贝尼地平恢复了对U - 46619增强的收缩反应,并保留了对乙酰胆碱的血管舒张反应。这些结果表明,贝尼地平预处理可预防缺血再灌注后的心肌损伤。贝尼地平的心脏保护作用可能部分归因于该药物对血管反应性的保护。